Vascular smooth muscle cell function modulation

Vascular smooth muscle cell function modulation refers to the process by which VSMCs, which are the main contractile cells in the arterial wall, switch between a contractile (quiescent) phenotype and a synthetic (proliferative/migratory) phenotype in response to environmental cues, mechanical signals, and growth factor stimulation. This phenotypic switching plays a critical role in vascular development, repair after injury, and is central to the pathogenesis of vascular diseases like atherosclerosis and hypertension. Modulation of VSMC function involves complex signaling pathways, including PI3K/Akt, ERK, and p38 MAPK, as well as changes in response to extracellular matrix stiffness and inflammatory cytokines. Pharmacological targeting of these pathways is challenging due to the broad physiological importance of VSMC plasticity in both health and disease. Key caveat: This is not a specific molecular target but a broad physiological process governed by numerous signals and cell states. For therapeutic targeting, clarification with a specific molecule, receptor, or signaling pathway related to VSMC modulation would be necessary.

Other names

vascular smooth muscle cell phenotypic modulationVSMC phenotype switchingVSMC plasticity

Inhibition of proliferation/migration; Promotion of contractile phenotype (through signaling pathway modulation e.g. PI3K/Akt); Inhibition of growth factor signaling (such as PDGF-BB inhibition)